Keywords
Extracellular matrixFibrosisMyofibroblastHepatic stellate cellPathophysiologyEtiologyPathologyPopulationChronic liver diseaseMedicineBiologyBioinformaticsCirrhosisInternal medicineCell biology
Affiliated Institutions
Related Publications
Molecular and cellular mechanisms of liver fibrosis and its regression
Chronic liver injury leads to liver inflammation and fibrosis, through which activated myofibroblasts in the liver secrete extracellular matrix proteins that generate the fibrou...
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Liver cirrhosis is a major cause of death worldwide and is characterized by extensive fibrosis. There are currently no effective antifibrotic therapies available. To obtain a be...
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is the leading chronic liver disease worldwide. Its more advanced subtype, nonalcoholic steatohepatitis (NASH), connotes progressive liv...
The gut-liver axis in liver disease: Pathophysiological basis for therapy
The gut-liver axis refers to the bidirectional relationship between the gut and its microbiota, and the liver, resulting from the integration of signals generated by dietary, ge...
Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis
Nonalcoholic steatohepatitis (NASH) can lead to complications such as liver failure, cirrhosis and hepatocellular carcinoma. The diagnostic gold standard for NASH is liver biops...
Publication Info
- Year
- 2018
- Type
- review
- Volume
- 65
- Pages
- 37-55
- Citations
- 1059
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1059
OpenAlex
Cite This
Maurizio Parola,
Massimo Pinzani
(2018).
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues.
Molecular Aspects of Medicine
, 65
, 37-55.
https://doi.org/10.1016/j.mam.2018.09.002
Identifiers
- DOI
- 10.1016/j.mam.2018.09.002